The goal of HSCT is to stop the autoimmune disease, Multiple Sclerosis in my case, and it is a bonus to get some functional recovery as well.
Here’s some peer reviewed scientific articles articles that have been published since 2014 regarding HSCT:
- Non-myeloablative hematopoietic stem cell transplantation (HSCT) is superior to disease modifying drug (DMD) treatment in highly active Relapsing Remitting Multiple Sclerosis (RRMS): interim results of the Multiple Sclerosis International Stem cell Transplant (MIST) Randomized Trial (S36.004)
Neurology Apr 2018, 90 (15 Supplement) S36.004
- Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial
Published: June 09, 2016 DOI: https://doi.org/10.1016/S0140-6736(16)30169-6
- Curing multiple sclerosis: Stem cells are starting to prove their value as medical treatments
Jan 23rd 2016 | From the print edition https://www.economist.com/printedition/2016-01-23
- Association of Nonmyeloablative Hematopoietic Stem Cell Transplantation With Neurological Disability in Patient With Relapsing-Remitting Multiple Sclerosis
JAMA. 2015;313(3):275-284. doi:10.1001/jama.2014.17986
- High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS): A 3-Year Interim Report
JAMA Neurol. doi:10.1001/jamaneurol.2014.3780
Published online December 29, 2014.
- The cost of multiple sclerosis drugs in the US and the pharmaceutical industry Too big to fail?
Published Online before print April 24, 2015
- Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience
Burman J, Iacobaeus E, Svenningsson A, et al.
J Neurol Neurosurg Psychiatry
Published Online First: February 19, 2014
- Stem Cell Transplant Effective as First Line in Aggressive MS
34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2018.
Abstract 230, presented October 11, 2018.
*Please Note: these articles are copyrighted and require proper citation reference to the Journal and authors.